Cheryl Marie Chapman, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 814 Village Sq, Gretna, NE 68028 Phone: 402-332-0220 Fax: 402-332-0440 |
Gretna Vision Source Optometrist Medicare: Medicare Enrolled Practice Location: 814 Village Sq, Gretna, NE 68028 Phone: 402-332-0220 Fax: 402-332-0440 |
Dr. Andria Nicole Louis, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 11532 Willow Park Drive, Suite 500, Gretna, NE 68028 Phone: 402-964-2378 Fax: 402-964-2224 |
Dr. Cathleen Roark, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 11844 Standing Stone Dr Ste 100, Gretna, NE 68028 Phone: 402-687-3435 |
Eyeconic Vision, Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 11844 Standing Stone Dr Ste 100, Gretna, NE 68028 Phone: 402-687-3435 |
Tiburon Family Eyecare, Pc Optometrist Medicare: Medicare Enrolled Practice Location: 11314 Wickersham Blvd, Ste. 300, Gretna, NE 68028 Phone: 402-933-5775 |
Sara Petska Optometrist Medicare: Accepting Medicare Assignments Practice Location: 814 Village Sq, Gretna, NE 68028 Phone: 402-332-0220 Fax: 402-332-0440 |
News Archive
New methods that enhance the quality of myocardial perfusion imaging were developed in a recent study completed at the University of Eastern Finland.
About 500,000 babies are born premature in the United States each year, according to the U.S. National Library of Medicine. Those infants, born before 37 weeks of gestation, will likely deal with the threat of numerous complications or even death.
A new version of an obesity drug that caused serious psychiatric side effects could help people lose pounds without experiencing the anxiety, depression and suicidal thoughts previously associated with it. The research, published in Bioorganic and Medicinal Chemistry, shows that the new version of the drug can still work without reaching the brain in rats, avoiding the side effects.
New insight into the aggressive behavior of certain adult B-acute lymphoblastic leukemias has provided researchers with a potential new prognostic biomarker and a promising new therapeutic target.
The well-worn notion that patients in the United States have unfettered access to the most expensive cancer drugs while the United Kingdom's nationalized health care system regularly denies access to some high-cost treatments needs rethinking, a team of bioethicists and health policy experts says in a report out today.
› Verified 1 days ago